1
Views
4
CrossRef citations to date
0
Altmetric
Original article

Active Chronic Hepatitis: Use of Bromosulphthalein Tm and S in Estimating Disease Activity

&
Pages 737-741 | Received 30 May 1972, Accepted 29 Aug 1972, Published online: 23 Feb 2010

REFERENCES

  • Cook, G. C., Mulligan, R. & Sherlock, S. 1971. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quart. J. Med. 40, 159–185.
  • Cook, G. C., Velasco, M. & Sherlock, S. 1968. Effect of corticosteroid therapy on bromo-sulphthalein excretion in active chronic hepatitis. Gut 9, 270–283.
  • Copenhagen Study Group for Liver Diseases. 1969. Effect of Prednisone on the survival of patients with cirrhosis of the liver. Lancet 1, 119.
  • Kater, R. M. H., Harrison, D. D. & Mistilis, S. P. 1967. Alterations in sulphobromophthalein sodium removal from blood in patients with pruritis of pregnancy. Gastroenterology 53, 941–946.
  • Mistilis, S. P. & Blackburn, C. R. B. 1970. Active chronic hepatitis. Amer. J. Med. 48, 484–495.
  • Mistilis, S. P. & Blackburn, C. R. B. 1967. 6-Mercaptopurine and azathioprine in the treatment of active chronic hepatitis. Aust. Ann. Med. 16, 305–311.
  • Mistilis, S. P., Skyring, A. P. & Blackburn, C. R. B. 1968. The natural history of active chronic hepatitis: 1. Clinical features, course, diagnostic criteria, morbidity, mortality and survival. Aust. Ann. Med. 17. 214–223.
  • Page, A. R., Good, R. A. & Pollara, B. 1969. Long-term results of therapy in patients with chronic liver disease associated with hyper-gammaglobulinaemia. Amer. J. Med. 47, 765–774.
  • Preisig, R., Williams, R., Sweeting, J. et al. 1966. Changes in sulphobromophthalein transport and storage by the liver during viral hepatitis in man. Amer. J. Med. 40, 170–183.
  • Rao, C. R. 1965. pp. 480–482 in Linear Statistical Inference and its Applications. John Wiley and Sons, New York.
  • Wheeler, H. O., Meltzer, J. I. & Bradley, S. E. 1960. Biliary transport and hepatic storage of sulphobromophthalein sodium in unanesthetized dog, in normal man and in patients with hepatic disease. J. clin. Invest. 39, 1131–1138.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.